In 2013, Biofarm had sales of RON117.6 million and a net profit of RON25.6 million.
The company’s operating profit grew 18.9%, from RON22.3 million in 2013 to RON26.5 million in 2014, the company said in statement to the Bucharest Stock Exchange Thursday.
Biofarm has a portfolio of around 200 products and is among the top ten medicines manufacturers by volume.
The pharma company is owned by SIF Muntenia (SIF4.RO), with 45.88%, while SIF Banat-Crișana (SIF1.RO) owns 19.53% and SIF Moldova (SIF2.RO) owns 12.26%.
Biofarm shares closed up 1.07% Thursday, at RON0.284 a share.